Home » Topics » BioWorld Science

BioWorld Science
RSS

Chugai reviews highlights of first quarter 2018

April 26, 2018

Novel glucose transporter inhibitor SRI-37919 reduces glioblastoma cell growth

April 26, 2018

AbbVie submits BLA to the FDA for risankizumab in moderate to severe plaque psoriasis

April 26, 2018

FDA accepts for review sBLA for Fluzone Quadrivalent 0.5 mL for younger children

April 26, 2018

STRIVE trial results show promise for AVXS-101 in spinal muscular atrophy type 1 patients

April 26, 2018

FDA grants fast track designation to SYNB-1618

April 26, 2018

First patient dosed in phase IIb study of chikungunya VLP vaccine

April 26, 2018

ADC Therapeutics terminates its ADCT-502 program in HER2-expressing solid tumors

April 26, 2018

Ono applies for manufacturing and marketing approval of encorafenib and binimetinib in Japan

April 26, 2018

Mirati Therapeutics updates progress of key programs

April 26, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...